BACKGROUND:
===========

With a prevalence of 20 % and an estimated growth of 7000 new cases per year in Denmark, chronic non-malignant pain comprises a major health problem \[[@R1], [@R2]\]. Chronic pain is often associated with psychological distress, which complicates adjustment to chronic pain \[[@R3], [@R4]\], and since eradication of pain is seldom an option, cognitive behavioral therapy has become part of standard treatment helping patients to cope with chronic pain. However, recently a growing number of studies have underlined the importance of fostering acceptance of the chronic condition as an important step in learning to cope with chronic pain. In the context of chronic pain acceptance can be defined as willingness to engage in activity with pain present and to allow the experience of pain without the need to avoid or control it \[[@R5]\].

Mindfulness meditation aims to teach the patient a state of being attentive to and aware of sensations, emotions and thoughts as they take place in the present, and thereby learning patients to accept the unavoidable pain and to disentangle themselves from their distressful thoughts and emotions \[[@R6]\]. Since Kabat-Zinn\'s introduction of mindfulness based stress reduction for chronic pain in the early eighties \[[@R6]\] various mindfulness-based interventions (MBIs) for chronic pain have been developed. Although the MBIs are not delivered as a homogenous programme, the overall aim of MBIs is to increase mental flexibility by keeping a non-evaluative and non-reactive contact with the present moment \[[@R7]\]. Mental flexibility and acceptance of the chronic pain condition has been associated with less psychological distress and better functioning despite of pain \[[@R8], [@R9]\]. Regarding effect sizes, the effect of MBIs in patients with chronic pain is comparable to that of cognitive behavioural therapy programmes with moderate effect sizes reported in relation to pain intensity, anxiety, depression, and physical health \[[@R10]-[@R13]\]. More specifically, increased level of mindfulness has been positively associated with lower levels of pain related anxiety, depression and disability \[[@R5], [@R14], [@R15]\], and lower levels of pain catastrophizing \[[@R14]\]. In addition, pain catastrophizing has been found to mediate the effect of mindfulness on disability and depression. Moreover, the effect of pain catastrophizing on depression was mediated by mindfulness \[[@R14]\]. Overall, the results indicate that level of mindfulness and acceptance of the chronic pain condition are positively correlated with improvement in disability and psychological functioning \[[@R9], [@R15], [@R16]\] and that level of mindfulness is an important mechanism associated with improvement in disability and psychological functioning. For these reasons it has been suggested to integrate both mindfulness and cognitive behaviour therapy into chronic pain management programmes \[[@R12]\]. Although correlations between mindfulness and acceptance and various measures of distress and well-being have been reported \[[@R15], [@R17]\], few studies have investigated the mechanisms of improved patient functioning in chronic pain \[[@R14]\].

The aims of the present study were to compare the effect of a 13-weeks cognitive behavioural therapy program with integrated mindfulness meditation (CBTm) in patients with chronic non-malignant pain with a control condition and to investigate the association between change in level of mindfulness and acceptance and the change in pain intensity and psychological distress.

It was hypothesised that 1) the CBTm program would reduce pain intensity and psychological distress compared to the control condition, 2) that the CBTm program would increase the level of mindfulness and acceptance of pain, and 3) that the change in level of mindfulness and acceptance both would be associated with the reduction in pain intensity and psychological distress.

METHODS
=======

Procedure
---------

In this pilot study, a convenience sample of patients with chronic non-malignant pain was recruited from a multidisciplinary pain centre in the region of Southern Denmark. The pain centre is a specialist, multidisciplinary pain rehabilitation centre that receives referrals from the municipal health care system in Denmark. The team of specialists includes anaesthesiologists, nurses, physiotherapists, social workers, as well as clinical psychologists. The majority of pain conditions are widespread or musculoskeletal in origin although patients with headache and abdominal pain, which may not be musculoskeletal in origin, are also referred for treatment \[[@R18]\]. Ninety-six invitation letters were consecutively mailed to participants prior to commencing the 13 weeks CBTm program. Patients in the control group were recruited from the pain center's waiting list. Eighty invitation letters were consecutively mailed to patients at the waiting list. Contact information for one of the investigators was provided to participants for study-related questions. Assessments of pain intensity and psychological distress were performed in both groups at baseline and after 13 weeks. Patients from both groups of the study continued to receive their usual medical care throughout the study period.

The research protocol was approved by the review board of the University of Southern Denmark. Furthermore, all participants in the study volunteered freely and written consent to participate in the research project was given at admission to the pain centre.

Outcome Measures
----------------

Questionnaires were given at baseline to assess patient characteristics. These included gender, age, and previous experience with relaxation or mindfulness. The primary outcome measures in this study were as follows:

### Pain Intensity

Pain intensity was assessed for peak pain intensity, lowest pain intensity, and average pain intensity over the past week as well as current pain. Each scale measured pain intensity on a 0-10 numerical rating scale (NRS) with 0 defined as no pain and 10 as the worst imaginable pain. For data analysis, a total pain intensity was calculated as the average of the four NRS scales. Internal consistency measured by Cronbach's alpha was good (T1-T2, α = .81-.90).

### Depression and Anxiety

The Hospital Anxiety and Depression Scale (HADS; \[[@R19]\]) was used to assess the level of depressive symptoms. The scale consists of 14 items, seven relating to anxiety (HADS-A) and seven to depression (HADS-D), with responses ranging from 0 (no symptoms) to 3 (maximum impairment). A cut-off score of ≥ 8 on each subscale was used in order to include all possible cases of depression and anxiety, as suggested by \[[@R19]\]. Internal consistency measured by Cronbach's alpha was good (T1-T2, α = .88-.89).

### Pain Catastrophizing

The Pain Catastrophizing Scale (PCS; \[[@R20]\]) was used to measure catastrophic thinking related to pain. The PCS instructions ask participants to reflect on past painful experiences, and to indicate the degree to which they experienced each of 13 thoughts or feelings when experiencing pain, on a five-point Likert scale with (0 = not at all, 4 = all the time). Scale sum score was calculated from all items, with a high score indicating a high level of pain catastrophizing. Internal consistency measured by Cronbach's alpha was good (T1-T2, α = .90-.94).

### Level of Mindfulness

Level of mindfulness was measured by the 15 items Mindfulness Attention and Awareness Scale (MAAS; \[[@R17]\]). A total score of mindfulness was comprised by the 15 items assessing the subjective experience of present moment attention and awareness in different situations (for example; "I find it difficult to stay focused on what's happening in the present"). Items were rated on a 6-point Likert scale (1=almost always to 6=almost newer), with higher scores indicating a greater degree of mindfulness (mindful behavior). The internal consistency of the MAAS as measured by Cronbach's alpha, was good (T1-T2, α = .89-.91).

### Acceptance

The Chronic Pain Acceptance Questionnaire (CPAQ; \[[@R21]\]) was used to measure acceptance of chronic pain. The scale is a 20-item measure of acceptance of chronic pain that yields a total score and two subscale scores for pain willingness and activity engagement. The scale has been widely used in studies of chronic pain and has good psychometric properties \[[@R21]\]. The internal consistency of the CPAQ as measured by Cronbach's alpha, was good (T1-T2, α = .86-.88).

The CBTm Program
----------------

For 13 consecutive weeks, the treatment group engaged in the CBTm program with classroom learning once per week for 2.5 hours. Homework and mindfulness exercises were assigned in between sessions. Written materials and audio CDs were provided to support home practice. The program was led by two professionally mindfulness based cognitive therapy (MBCT) trained psychologists and long term meditators and conducted in groups of 8-10 patients. The main goal of the program was not eradication of pain symptoms, but management of the pain condition and reduction of psychological distress. The program was delivered as a standard cognitive behavioural therapy program for chronic pain \[[@R22]\] integrating elements of mindfulness training as described in the MBCT program \[[@R23]\]. The program consisted of the following topics and exercises: education in pain physiology and theory, pain coping strategies, mindfulness exercises, activity-rest scheduling, assertive communication, acceptance strategies and restructuring of maladaptive thoughts.

Statistics
----------

Prior to data analysis, the data were screened for errors and missing values. The percentage of missing values was small (\< 5%). The Expectation Maximization algorithm was used to impute missing data \[[@R24]\]. Results are presented as mean and standard deviation (SD) in the text and mean and standard error of the mean (SEM) in figures. None of the measured variables deviated from normality (Kolmogorov-Smirnoff test: *P* \> 0.05) and parametric statistics were used for analysis. Baseline characteristics for all included patients were analysed with chi squares test for dichotomous data and with independent sample t-test for continuous data. Moreover, a dropout analysis comparing baseline characteristics for patients who completed the study and patients who dropped out was performed. Two-way repeated measures analysis of variances (ANOVAs) were used for analysis of the outcome measures for the patients who completed the study with the factor *time* (baseline and follow up) as repeated measure and *group* (treatment and control) as between factor. In case of significant factors or interactions, the Newman-Keuls (NK) post-hoc test was used incorporating correction for the multiple comparisons. Percentages of patients in the two groups with scores ≥ 8 on HADS (depression and anxiety) at follow up were analysed with chi squares test.

*P*values less than 0.05 in the ANOVAs were considered significant. Effect sizes of the difference in outcome measures between groups were calculated based on Hedges' g, due to dissimilar group sizes. Finally, Pearson correlations were used to determine how changes in pain intensity and psychological distress were associated with changes in mindfulness attention and awareness and acceptance of chronic pain. To address the multiple correlational analyses, we applied a more conservative criterion (*p* ≤ 0.01) to all correlational analyses as a means of reducing the likelihood of type I errors without overly inflating the risk of type II errors.

RESULTS
=======

Baseline Characteristics
------------------------

Fig. (**[1](#F1){ref-type="fig"}**) illustrates the patient flow in this study. Of the 96 patients who were eligible to participate in the treatment group, 80 patients completed baseline questionnaires and 50 patients completed questionnaires after 13 weeks. Of the 80 patients who were eligible to participate in the control group, 45 patients completed baseline questionnaires and 20 patients completed questionnaires after 13 weeks.

Table **[1](#T1){ref-type="table"}** compares baseline characteristics in the treatment and control group at baseline. A significantly larger percentage of the patients in the treatment group had previous experience with relaxation compared with patients in the control group. There was no significant difference in demographics, pain intensity or psychological variables between the groups at baseline.

Drop-out Analysis
-----------------

Twenty-five patients from the control group did not complete questionnaires after 13 weeks. There was no significant difference in pain intensity or psychological variables between patients who dropped out and patients who completed the study (-1.04 \< t(43) \< 1.67, *P* \> 0.1). Patients in the control group who completed the study was older compared with dropouts; however, the difference did not reach significance (t(43) = 1.97, *P* = 0.06).

Thirty patients from the treatment group did not complete questionnaires after 13 weeks. There was no significant difference in demographics, pain intensity or psychological variables between patients who dropped out and patients who completed the study (-1.70 \< t(78) \< 1.11, *P* \> 0.09).

Follow-up
---------

The baseline and follow-up scores for patients in the treatment and control groups who completed the study are presented in Table **[2](#T2){ref-type="table"}**.

### Pain Intensity

There was no significant main effects or interactions in the ANOVA (Treatment group: from 5.9 ± 1.3 to 5.9 ± 1.9; Control group: from 6.3 ± 1.8 to 6.6 ± 2.0; F(1,68) \< 0.61, *P* \> 0.43) indicating that CBTm did not reduce pain intensity compared with the waiting list.

### Depression and Anxiety

The treatment group had a reduction in the score on the depression subscale from baseline to follow-up, whereas the control group had an increase (Treatment group: from 7.7 ± 3.8 to 6.0 ± 3.4; Control group: from 7.5 ± 4.6 to 8.1 ± 5.2; Effect size: 0.56). A significant interaction between group and time was found in the ANOVA (F(1,68) = 9.82, *P* \< 0.003; Fig. **[2](#F2){ref-type="fig"}**), with post hoc test showing a significant decrease in the depression score at follow-up in the treatment group compared with baseline and the control group (NK: *P* \< 0.004). Furthermore, significantly fewer percent of the patients (30.0%) in the treatment group had a total score of ≥ 8 on the depression subscale compared with patients in the control group (65.0 %; Chi Square, *P* \< 0.007).

Both groups had a reduction in the score on the anxiety subscale from baseline to follow-up (Treatment group: from 8.7 ± 3.6 to 7.0 ± 3.3; Control group: from 10.3 ± 4.5 to 9.6 ± 5.1; Effect size: 0.36) and the ANOVA demonstrated a significant main effect of time (F(1,68) = 8.10, *P* \< 0.006), with post hoc test showing a significant decrease in the anxiety score at follow up in both groups compared with baseline (NK: *P*\< 0.003). However, significantly fewer percent of the patients (36.0%) in the treatment group had a total score of ≥ 8 on the anxiety subscale in the HADS compared with patients in the control group (65.0 %; Chi Square, *P* \< 0.03).

### Pain Catastrophizing

Both groups had a reduction in pain catastrophizing from baseline to follow-up (Treatment group: from 28.0 ± 8.6 to 21.0 ± 8.9; Control group: from 33.1 ± 9.4 to 31.8 ± 10.7; Effect size: 0.53). A significant interaction was found in the ANOVA between group and time (F(1,68) = 4.86, *P*\< 0.04; Fig. **[3](#F3){ref-type="fig"}**), with post hoc test showing a significant decrease in the treatment group at follow-up compared with baseline (NK: *P* \< 0.001). The treatment group had a significant lower score at baseline and follow-up compared with the control group (NK: *P* \< 0.02).

### Acceptance

Both groups had an increase in the total score of the Chronic Pain Acceptance Questionnaire from baseline to follow-up (Treatment group: from 52.6 ± 17.2 to 60.7 ± 15.0; Control group: from 46.6 ± 17.3 to 49.4 ± 23.3; Effect size: 0.51) as well as in the willingness to be active despite pain subscale (Treatment group: from 20.6 ± 9.4 to 25.6 ± 8.3; Control group: from 17.0 ± 7.9 to 20.4 ± 10.7; Effect size: 0.30). A significant main effect of time was found in the ANOVA of the total score of CPAQ as well as in the willingness to be active despite pain subscale (F(1,68) = 11.64, *P* \< 0.002 and F(1,68) = 18.43, *P* \< 0.001, respectively) with post hoc test showing a significant increase in the scores at follow up in both groups compared with baseline (NK: *P* \< 0.001).

The treatment group had an increase in the activity engagement subscale from baseline to follow-up (from 32.2 ± 10.9 to 35.1 ± 10.7), whereas the control group had a decrease (from 29.6 ± 11.3 to 29.0 ± 15.1). The ANOVA approached a significant interaction between time and group (F(1,68) \< 3.36, *P* = 0.07).

### Mindfulness Attention and Awareness

The treatment group had an increase in the score on the MAAS from baseline to follow-up, whereas the control group had a decrease (Treatment group: from 54.0 ± 12.4 to 57.9 ± 10.8; Control group: from 57.0 ± 14.6 to 53.4 ± 15.7; Effect size: 0.54). A significant interaction between group and time was found in the ANOVA (F(1,68) = 5.90, *P* \< 0.02), however, post hoc test failed to reach significance between baseline or follow-up or between the groups at any time point (NK: *P* \> 0.08).

### Associations between Changes in MAAS/CPAQ and Changes in Pain Intensity and Psychological Distress

Significant correlations were found between change in the MAAS score from baseline to follow-up and changes in psychological distress indicating that increased level of mindfulness had a positive effect on changes in psychological distress following treatment. The correlations are as follows: Depression score (r(68) = 0.31, *P* = 0.01), pain catastrophizing scale (r(68) = 0.45, *P* \< 0.001), anxiety score (r(68) = 0.38, *P* = 0.001). Significant correlations were also found between change in the CPAQ score from baseline to follow-up and change in the pain catastrophizing scale (r(68) = 0.51, *P* \< 0.001), and anxiety score (r(68) = 0.33, *P* = 0.005). Correlations between pain intensity and MAAS (r(68) = 0.25, *P* = 0.04), and pain intensity and CPAQ (r(68) = 0.27, *P* = 0.02) approached significance.

There was no significant correlation between change in the CPAQ score from baseline to follow-up and change in the MAAS score (r(68) = 0.01, *P* = 0.91).

DISCUSSION
==========

This pilot study investigated the effect of a 13 weeks cognitive behavioural therapy program with integrated mindfulness meditation (CBTm). As hypothesized, the program reduced psychological distress (pain-catastrophizing, depression, and anxiety) compared to the control group. Although, the CBTm group increased in level of mindfulness and acceptance and the controls decreased, the difference was not significant. Also, as hypothesized, the increased level of mindfulness and acceptance were negatively associated with all measures of psychological distress with the exception of depression, which was only associated with change in level of mindfulness.

The findings of reduced psychological distress are in accordance with previous studies reporting moderate effect sizes of both MBI and cognitive behavioural therapy \[[@R10], [@R13]\]. Surprisingly, changes in level of mindfulness did not correlate with changes in acceptance, although both scores correlated with changes in psychological distress. This finding may indicate that different mechanisms are targeted with cognitive behavioural therapy techniques and mindfulness. In specific, the finding that only change in level of mindfulness was associated with change in depression could indicate that one of the mechanisms of mindfulness is the ability to uncouple the emotional components of pain, and thereby reduce symptoms of distress. The result is in accordance with the theoretical rationale for mindfulness emphasizing that mental flexibility is important in coping with distress \[[@R25]\]. Moreover, the finding that changes in level of mindfulness did not correlate with changes in acceptance may indicate that acceptance is not a strict prerequisite for coping with pain related distress. For this reason the integration of mindfulness meditation in cognitive behavioural therapy programmes may have some advantages above cognitive behavioural therapy alone. However, this still needs to be tested in a randomized controlled trial in the context of chronic pain rehabilitation. Although, more follow-up studies are needed, evidence indicates that the effect of MBIs on pain related distress may be maintained up to 3-years post-treatment \[[@R26]\]. In comparison, the long-term effects of cognitive behavioural therapy for chronic pain are quite modest \[[@R13]\]. Hence, it may be beneficial integrating more MBI techniques into cognitive behavioural therapy programmes for chronic pain.

Limitations
-----------

Limitations regarding the interpretation of the results from this study should be taken into consideration. First of all, this study was intended as a pilot study and is as such limited by the small sample size. Limitations include lack of statistical power as well as risk of false positive results and the results should be interpreted with care. Larger studies should confirm the findings of this study. Also, the lack of randomization and the short follow-up time are major limitations. Secondly, the high level of drop-outs, especially in the control group is a limitation. Moreover, the CBTm group had more prior experience with relaxation, compared to the control group, which may be a confounder. In spite of these limitations, this pilot study adds important knowledge about possible mechanisms of mindfulness and acceptance in relation to coping with chronic pain. In particular, the associations between increase in both mindfulness and acceptance and positive change in psychological distress and pain is encouraging.

CONCLUSION
==========

A 13-weeks CBTm program reduced depression and pain catastrophizing in patients with chronic non-malignant pain compared with the control group. The reduction in catastrophizing and anxiety were negatively associated with the increased level of mindfulness and acceptance and the reduction in depression was negatively associated with the increased level of mindfulness. For these reasons, the integration of mindfulness into cognitive behavioural therapy programmes for chronic pain seems promising.
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###### 

Patient characteristics in the control and treatment group at baseline.

  ------------------------------------------------------------------------------------------------------------------
  Variable                               Control group\   Treatment group\   *P*\
                                         (n = 45)         (n = 80)           value
  -------------------------------------- ---------------- ------------------ ---------------------------------------
  Age (years)                            42.9 ± 11.0      44.8 ± 11.8        0.38^[a](#T1F1){ref-type="table-fn"}^

  Sex (F/M)                              35/10            63/17              0.90^[b](#T1F2){ref-type="table-fn"}^

  Previous experience with relaxation    10 (22.2%)       31 (40.3%)         0.04^[b](#T1F2){ref-type="table-fn"}^

  Previous experience with mindfulness   7 (15.6%)        20 (26.3%)         0.17^[b](#T1F2){ref-type="table-fn"}^

  Pain intensity (NRS: 0-10)             6.4 ± 1.5        6.0 ± 1.4          0.18^[a](#T1F1){ref-type="table-fn"}^

  Depression (HAD: 0-21)                 7.8 ± 4.5        7.4 ± 4.2          0.60^[a](#T1F1){ref-type="table-fn"}^

  Subjects with depression (HAD ≥ 8)     22 (48.9%)       40 (50%)           0.91^[b](#T1F2){ref-type="table-fn"}^

  Anxiety (HAD: 0-21)                    9.6 ± 4.9        8.4 ± 3.6          0.11^[a](#T1F1){ref-type="table-fn"}^

  Subjects with anxiety (HAD ≥ 8)        28 (62.2%)       47 (58.8%)         0.70^[b](#T1F2){ref-type="table-fn"}^

  Pain Catastrophizing (PCS: 0-52)       30.5 ± 9.4       27.0 ± 10.1        0.06^[a](#T1F1){ref-type="table-fn"}^

  Level of mindfulness (MAAS: 15-90)     56.7 ± 16.5      55.1 ± 13.4        0.56^[a](#T1F1){ref-type="table-fn"}^

  Pain Acceptance (CPAQ: 0-120)          49.4 ± 16.0      53.1 ± 17.1        0.24^[a](#T1F1){ref-type="table-fn"}^
  ------------------------------------------------------------------------------------------------------------------

^a^ Independent T-Test

^b^ Chi Square Test

'NRS': Numerical Rating Scale, 'HAD': Hospital Anxiety and Depression Scale, 'PCS': Pain Catastrophizing Scale, 'MAAS': Mindfulness Attention and Awareness Scale, 'CPAQ': Chronic Pain

###### 

Mean ± SD (n=70) clinical pain scores and psychological variables before and after 13 weeks in the treatment and control groups. Significant differences between baseline and follow-up (\*, *P* \< 0.05), and significant differences between groups (†, *P* \< 0.05).

  -------------------------------------------------------------------------------------------------------------------------
  Variable                              Treatment group (N=50)   Control group (N=20)   Effect size                 
  ------------------------------------- ------------------------ ---------------------- ------------- ------------- -------
  Peak intensity (NRS: 0-10)\           5.9±1.3\                 5.9±1.9\               6.3±1.8\      6.6±2.0\      0.00\
  Depression (HAD: 0-21)\               7.7±3.8\                 6.0±3.4\*†\            7.5±4.6\      8.1±5.2\      0.56\
  Anxiety (HAD: 0-21)\                  8.7±3.6\                 7.0±3.3\*\             10.3±4.5\     9.6±5.1\*\    0.36\
  Pain Catastrophizing (PCS: 0-52)\     28.0±8.6\                21.0±8.9\*†\           33.1±9.4\     31.8±10.7\    0.53\
  Level of mindfulness (MAAS: 15-90)\   54.0±12.4\               57.9±10.8\             57.0±14.6\    53.4±15.7\    0.54\
  Pain Acceptance (CPAQ: 0-120)         52.6±17.2                60.7±15.0\*            46.6±17.3     49.4±23.3\*   0.51

  -------------------------------------------------------------------------------------------------------------------------
